Taconic Biosciences Expands Microbiome Product and Service Platform

Taconic Biosciences Expands Microbiome Product and Service Platform

ID: 538564

(Thomson Reuters ONE) -


HUDSON, N.Y., April 26, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global
leader in genetically engineered mouse models and associated services and the
only commercial provider of germ-free mice, announced that effective April
26, 2017 they will expand their microbiome product and services platform to
include custom Fecal Microbiota Transplantation (FMT) services. To support these
new FMT services, Taconic will also offer custom germ-free derivations using
either client mouse models, Taconic's commercial offerings, or mice sourced from
third parties.

This new FMT service offering capitalizes on Taconic's decades of microbiome
experience, existing portfolio of germ-free offerings including Germ-Free
C57BL/6NTac and Swiss Webster mice, and ability to derive germ-free animals from
Taconic's large catalog of mutant mice or client-provided models.

Dr. Alexander Maue, Taconic Biosciences' portfolio director for microbiome
products and services, commented, "The germ-free mouse is the ideal substrate to
evaluate the properties of complex or defined gut microbiota following FMT.
Axenic mice transplanted with donor microbiota can be used to assess the effects
of gut bacteria on a wide range of biological systems, including but not limited
to, immunity, neurodegenerative diseases, obesity, and diabetes."

"Our custom germ-free derivation services enable Taconic to generate initial
cohorts of up to 40 germ-free animals, allowing researchers to generate rapid
study cohorts."

Prior to the start of any custom FMT project or germ-free derivation service,
Taconic consults with the client to understand their research goals and develop
a strategy for project execution. A dedicated Project Manager will keep clients
updated throughout the project. Following FMT, Taconic offers a range
of husbandry options to accommodate studies of all sizes and durations including




options for isolators and state of the art individually ventilated cages (IVCs).

In addition to providing microbiome products and services, Taconic also is a
fully-licensed provider of rodent model generation services and has twenty years
of model design experience. Complimenting this expertise is Taconic's unique
capability of providing a seamless transition from model design to breeding and
colony management, thus offering customers a complete solution. These scientific
services include acquiring or generating, importing, licensing, breeding,
testing, preparing, and distributing genetically engineered models to any
location worldwide.

To learn more about Taconic's microbiome products and services, please contact
Taconic Biosciences at 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05
in Europe or at info(at)taconic.com.

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully-licensed, global leader in genetically engineered
rodent models and services. Founded in 1952, Taconic helps biotechnology
companies and institutions acquire, custom generate, breed, precondition, test,
and distribute valuable research models worldwide.  Specialists in genetically
engineered mouse and rat models, precision research mouse models, and integrated
model design and breeding services, Taconic operates three service laboratories
and six breeding facilities in the U.S. and Europe, maintains distributor
relationships in Asia and has global shipping capabilities to provide animal
models almost anywhere in the world.

Media Contact:
Kelly Owen Grover
Director of Marketing Communications
(518) 697-3824
kelly.grover(at)taconic.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Taconic Biosciences via GlobeNewswire




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Financière de Tubize SA: Approval of dividend UNIBAIL-RODAMCO SE: Results of the Combined Annual General Meeting of April 25, 2017
Bereitgestellt von Benutzer: hugin
Datum: 26.04.2017 - 17:18 Uhr
Sprache: Deutsch
News-ID 538564
Anzahl Zeichen: 4332

contact information:
Town:

Hudson



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 212 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Taconic Biosciences Expands Microbiome Product and Service Platform"
steht unter der journalistisch-redaktionellen Verantwortung von

Taconic Biosciences (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Taconic Biosciences Generates Vici Syndrome Mouse Model ...

HUDSON, NY -- (Marketwired) -- 02/17/17 -- Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, announced it has generated a novel mouse model of Vici syndrome for use by two investigators studying th ...

Alle Meldungen von Taconic Biosciences



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z